Navigation Links
Amgen Oncology Data to be Presented at ASCO Annual Meeting
Date:5/18/2011

(mPC)

(Abstract 4049) Poster on Saturday, June 4, 8:00 a.m. - 12:00 p.m., Hall A


  • A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC)

  • (Abstract 544) Poster on Monday, June 6, 1:00 p.m. - 5:00 p.m., Hall A


  • An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

  • (Abstract LBA7512) Poster Discussion on Monday, June 6, 2:00 p.m. - 6:00 p.m., E450aFor the latest updates on Amgen's presence at ASCO and other Amgen news, follow us on Twitter @Amgen.About XGEVAXGEVA is the first and only RANK Ligand inhibitor approved by the U.S. Food and Drug Administration (FDA) that is indicated for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. XGEVA is not indicated for the prevention of SREs in patients with multiple myeloma. XGEVA is the first novel bone metastases treatment for patients with advanced cancer in nearly a decade. Delivered as an every four week 120 mg subcutaneous injection, XGEVA provides a unique option for urologists and oncologists to prevent SREs in patients with advanced cancer.

    XGEVA is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and survival of osteoclasts (the cells that break down bone). XGEVA prevents RANK Ligand from activating its receptor, RANK, on the surface of osteoclasts, thereby decreasing bone destruction.

    The clinical program for XGEVA spanned more than 50 tumor types in more than 5,700 patients. In clinical trials, XGEVA demonstrated a clinically meaningful improvement
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
    2. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
    3. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
    4. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
    5. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
    6. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
    7. Amgen to Webcast 2011 Business Review Meeting on April 21
    8. Amgen Announces Webcast of 2011 First Quarter Financial Results
    9. Amgen Establishes Commercial Operations in Brazil
    10. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
    11. Amgen Donates $1 Million to Help Japanese Disaster Victims
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
    (Date:7/30/2015)... Calif. , July 30, 2015 Edwards Lifesciences ... science of heart valves and hemodynamic monitoring, today announced that ... Board of Directors. "Bob is an ardent champion ... a true privilege to have him on Edwards, board as ... Mussallem , Edwards, chairman and CEO.  "Bob has provided a ...
    (Date:7/30/2015)... , July 30, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and ... entered into non-exclusive Development Agreements with Dexcom, Inc. ... insulin pumps with the Dexcom G5 and G6 ... Tandem,s next generation pump platform with Dexcom,s future ...
    Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
    ... Entry into Oncology Market; Rosetta to Receive Milestones ... DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13 ... company, and Rosetta Genomics Ltd. (Nasdaq: ... announced the execution of a license and collaboration ...
    ... - Additional Presentations Underscore Potency, Binding Capabilities for ... 9 InNexus Biotechnology Inc. (Toronto Stock Exchange: ... commercializing the next generation of monoclonal antibodies based ... today that the company will be presenting new ...
    Cached Medicine Technology:Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 2Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 3Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 4Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 5Prometheus and Rosetta Genomics Announce License and Collaboration Agreement 6AACR Data Highlights InNexus Preclinical Antibody Candidate 2
    (Date:8/1/2015)... ... ... ever wondered what “Karma” really means? Does it even exist? Can I change my Karma? ... gave birth to Hinduism, is one of the most ancient spiritual and mystical traditions on ... the wisdom of this heritage, Karma is a very real and powerful force in our ...
    (Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, ... announcing the unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. ... the founders of both companies have agreed to join their missions of purpose together ...
    (Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic ... very first small business donation to kick off the campaign for healing and Well-Being. ... legacy includes a complete line of raw, organic hair care products, as well as ...
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source of ... the MGM Grand Garden Arena. Fans of every genre of music will have an ... 18th, the first day of the festival, the following artists will perform: Sam Smith, ...
    (Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
    Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2
    ... in cooperation with the National Institute of Justice (NIJ), ... test personal body armor. The deadline for inclusion in ... 15, 2007. , Personal body armor can mean the ... who routinely put themselves at risk to protect the ...
    ... [Brown University] Researchers at The Warren Alpert Medical School ... patients to explain rapid tests for HIV, a relatively new ... video gives an overview of rapid HIV tests, which can ... or a blood draw. Results are available in minutes. Brown ...
    ... innovative,leader in the development and marketing of products for ... T. IntVeld has,joined the Company as Vice President of ... oversee the establishment and expansion,of sales activities in the ... Bryce as a member of our executive management,team," commented ...
    ... WEST PALM BEACH, Fla., Dec. 12 The Quantum,Foundation has ... initiative with a new pool of $500,000 that will be ... to assist existing or new,area clinics in their efforts to ... "We are doing this for the simple reason that we ...
    ... Dec. 12 Yesterday, the U.S. Court of,Appeals ... Drug Enforcement,Administration,s (DEA) 2006 revocation of Wedgewood Pharmacy,s ... the DEA,s,decision since it first was issued., ... of the,DEA,s decision and the DEA,s denial of ...
    ... 12 Red Cross volunteer,Krysta Leigh Meinzer is ... mtvU, MTV,s 24-hour college network, profiling standout student,activists ... for,blood donations in an episode of the show, ... at mtvU.com and Think.MTV.com., (Photo: http://www.newscom.com/cgi-bin/prnh/20071212/DC09732 ...
    Cached Medicine News:Health News:New accreditation program for body armor testing laboratories 2Health News:Brown researchers create first-ever HIV rapid test video 2Health News:Brown researchers create first-ever HIV rapid test video 3Health News:Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales 2Health News:Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers 2Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 2Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 3Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 4Health News:Red Cross Blood Donor and Volunteer Featured on mtvU's 'CAUSE EFFECT' 2
    Donor Screen & Confirmation Kit...
    ... antibody gives positive staining of prostatic ... hyperplasia. In cases of prostatic cancer, ... give definite but weak staining or ... cells; this pattern of staining permits ...
    ... comprehensive line of pregnancy tests including rapid ... convenient one-step stick and cassette formats. The ... Easy HCG is a 25 mIU urine ... HCG II provides 25mIU sensitivity for ...
    For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
    Medicine Products: